Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines : Med e-News

News

Published: 19Jun2020

Live 2020 . Saint-Gobain Life Sciences and Kanyr Pharma partner with clinical experts at the Research Institute of McGill University Health Centre and engineers at McGill to develop new cell culture technologies.

https://publications.mcgill.ca/medenews/2020/06/17/interdisciplinary-consortium-receives-grant-to-develop-next-generation-cell-based-cancer-vaccines/

Tags: 
Back to top